Endocyte, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Endocyte with three other
companies in this sector in the United States:
RegeneRx Biopharmaceuticals, Inc.
sales of $56,652.00
Sangui Biotech International, Incorporated
During the year ended December of 2017, sales at
Endocyte were $70,000.00 .
a very small
increase of 0.0%
versus 2016, when the company's sales were $70,000.00 .